Diego Cadavid

Person

Bedford, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
LINGO-1 antagonists and uses for treatment of demyelinating disorders
- Patent number 10,435,467
- Issue date Oct 8, 2019
- Biogen MA Inc.
- Diego Cadavid
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cognitive composite parameters and uses thereof for evaluating mult...
- Patent number 9,717,453
- Issue date Aug 1, 2017
- Biogen Idec MA Inc.
- Diego Cadavid
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
LINGO-1 ANTAGONISTS AND USES FOR TREATMENT OF DEMYELINATING DISORDERS
- Publication number 20210277111
- Publication date Sep 9, 2021
- Biogen MA Inc.
- Diego Cadavid
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Combination Therapies and Uses for Treatment of Demyelinating Disor...
- Publication number 20210260185
- Publication date Aug 26, 2021
- Biogen MA Inc.
- Diego Cadavid
- G01 - MEASURING TESTING
Information Patent Application
Combination Therapies and Uses for Treatment of Demyelinating Disor...
- Publication number 20200276303
- Publication date Sep 3, 2020
- Biogen MA Inc.
- Diego Cadavid
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LINGO-1 ANTAGONISTS AND USES FOR TREATMENT OF DEMYELINATING DISORDERS
- Publication number 20200216533
- Publication date Jul 9, 2020
- Biogen MA Inc.
- Diego Cadavid
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Combination Therapies and Uses for Treatment of Demyelinating Disor...
- Publication number 20190038744
- Publication date Feb 7, 2019
- Biogen MA Inc.
- Diego Cadavid
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LINGO-1 ANTAGONISTS AND USES FOR TREATMENT OF DEMYELINATING DISORDERS
- Publication number 20180148505
- Publication date May 31, 2018
- Biogen MA Inc.
- Diego Cadavid
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIOMARKERS PREDICTIVE OF THERAPEUTIC RESPONSIVENESS TO IFNB AND USE...
- Publication number 20160045570
- Publication date Feb 18, 2016
- Biogen MA Inc.
- Steven Bushnell
- G01 - MEASURING TESTING
Information Patent Application
COMBINATION THERAPIES AND USES FOR TREATMENT OF DEMYELINATING DISOR...
- Publication number 20150238602
- Publication date Aug 27, 2015
- Biogen Idec MA Inc.
- Diego Cadavid
- G01 - MEASURING TESTING
Information Patent Application
DISEASE PROGRESSION PARAMETERS AND USES THEREOF FOR EVALUATING MULT...
- Publication number 20150220693
- Publication date Aug 6, 2015
- Biogen Idec MA Inc.
- Diego Cadavid
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Application
COGNITIVE COMPOSITE PARAMETERS AND USES THEREOF FOR EVALUATING MULT...
- Publication number 20150110741
- Publication date Apr 23, 2015
- Biogen Idec MA Inc.
- Diego Cadavid
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIOMARKERS PREDICTIVE OF THERAPEUTIC RESPONSIVENESS TO IFNB AND USE...
- Publication number 20120328567
- Publication date Dec 27, 2012
- Steven Bushnell
- G01 - MEASURING TESTING

Diego Cadavid

Person

Patents Grantslast 30 patents

LINGO-1 antagonists and uses for treatment of demyelinating disorders

Cognitive composite parameters and uses thereof for evaluating mult...

Patents Applicationslast 30 patents

LINGO-1 ANTAGONISTS AND USES FOR TREATMENT OF DEMYELINATING DISORDERS

Combination Therapies and Uses for Treatment of Demyelinating Disor...

Combination Therapies and Uses for Treatment of Demyelinating Disor...

LINGO-1 ANTAGONISTS AND USES FOR TREATMENT OF DEMYELINATING DISORDERS

Combination Therapies and Uses for Treatment of Demyelinating Disor...

LINGO-1 ANTAGONISTS AND USES FOR TREATMENT OF DEMYELINATING DISORDERS

BIOMARKERS PREDICTIVE OF THERAPEUTIC RESPONSIVENESS TO IFNB AND USE...

COMBINATION THERAPIES AND USES FOR TREATMENT OF DEMYELINATING DISOR...

DISEASE PROGRESSION PARAMETERS AND USES THEREOF FOR EVALUATING MULT...

COGNITIVE COMPOSITE PARAMETERS AND USES THEREOF FOR EVALUATING MULT...

BIOMARKERS PREDICTIVE OF THERAPEUTIC RESPONSIVENESS TO IFNB AND USE...